19
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T28141 | Nek2-IN-5 | NCL00017509 | MAPK |
Nek2-IN-5 (NCL00017509) is a potent and selective inhibitor of NIMA-related kinase 2 (Nek2). | |||
T73287 | Nek2-IN-6 | ||
Nek2-IN-6 inhibitor . | |||
T11960 | MBM-55 | GSK-3 , MAPK , DYRK , Akt , Chk , Bcr-Abl , CDK , S6 Kinase , Aurora Kinase | |
MBM-55 is an effective inhibitor of NIMA related kinase 2 (NEK2) with an IC50 of 1 nM. MBM-55 effectively inhibits the proliferation of cancer cells by inducing cell cycle arrest and apoptosis. | |||
T8216 | T-1101 tosylate | TAI-95 tosylate | Apoptosis , Microtubule Associated |
T-1101 tosylate (TAI-95 tosylate) is an inhibitor of Hec1/Nek2, with antitumor activity. | |||
T6180 | INH6 | Apoptosis , Microtubule Associated | |
INH6, an effective Hec1 inhibitor, selectively disrupts the Hec1/Nek2 interaction and induces chromosome mis-alignment. | |||
T11961 | MBM-55S | GSK-3 , MAPK , Akt , Bcr-Abl , CDK , S6 Kinase , Aurora Kinase | |
MBM-55S is an effective inhibitor of Nek2 with an IC50 of 1 nM. MBM-55S indecus cell cycle arrest and apoptosis thereby inhibiting the proliferation of cancer cells. MBM-55S shows antitumor activities. | |||
T6691 | TAI-1 | Apoptosis , Microtubule Associated | |
TAI-1 is a potent and specific Hec1 inhibitor, which disrupts Hec1-Nek2 protein interaction. | |||
T2502 | INH1 | IBT13131 | Apoptosis , Microtubule Associated |
INH1 (IBT13131) is a cell-permeable Hec1 inhibitor that specifically disrupts the Hec1/Nek2 interaction. | |||
T11657 | INH154 | Others | |
INH154 is a highly potent inhibitor for Nek2 and Hec1 binding (INH), with IC50s of 120 nM and 200 nM for INH in MB468 and Hela cells. | |||
T9880 | ZINC05007751 | MAPK | |
ZINC05007751 is an effective inhibitor of NIMA-related kinase NEK6 (IC50 = 3.4 μM). ZINC05007751 is very selective against NEK1 and NEK6 with no significant activity observed against NEK2, NEK7, and NEK9. | |||
T38710 | JH295 | ||
JH295 is a highly potent and selective inhibitor of NIMA-related kinase 2 (Nek2), exhibiting irreversible inhibition activity with an IC 50 value of 770 nM. This compound effectively inhibits cellular Nek2 using the alky... | |||
T11959 | MBM-17S | Aurora Kinase | |
MBM-17S, a potent NIMA-related kinase 2 (Nek2) inhibitor with an IC50 of 3 nM, effectively inhibits cancer cell proliferation by inducing cell cycle arrest and apoptosis. It demonstrates antitumor activities without evid... | |||
T11958 | MBM-17 | Aurora Kinase | |
MBM-17 is a potent inhibitor of NIMA-related kinase 2 (Nek2,IC50 of 3 nM). It effectively inhibits the proliferation of cancer cells by inducing cell cycle arrest and apoptosis. | |||
T28498 | Rac-CCT-250863 | ||
Rac-CCT-250863, a potent Nek2 inhibitor, exhibits selectivity for Nek2 over PLK1, MPS1, Cdk2 and Aurora A. | |||
T27052 | CMP3a | CMP-3a,CMP 3a | |
CMP3a is a NEK2 kinase inhibitor. CMP3a efficiently attenuated GBM growth in a mouse model and exhibited a synergistic effect with radiotherapy. Targeting NEK2 attenuates glioblastoma growth and radioresistance by destab... | |||
T24130 | HCI-2184 | HCI2184,HCI 2184 | |
HCI-2184 is an inhibitor of AXL kinase and Nek2 that acts by successfully mitigating drug resistance in bortezomib-resistant multiple myeloma. | |||
T81696 | NBI-961 | ||
NBI-961, a potent NEK2 inhibitor, suppresses proteasomal degradation and effectively induces G2/mitosis arrest and apoptosis within diffuse large B cell lymphoma (DLBCL) cells [1]. | |||
T61061 | JH295 hydrate | ||
JH295 hydrate is a potent, irreversible and selective NIMA-related kinase 2 (Nek2) inhibitor that inhibits cellular Nek2 by Cys22 alkylation (IC50 = 770 nM). JH295 hydrate is not active against the mitotic kinases, Cdk1,... | |||
T28498L | Rac-CCT-250863 HCl | rac-CCT-250863 HCl(1364269-06-6 Free base) | Apoptosis |
rac-CCT-250863 HCl is a selective and reversible inhibitor of NEK 2. rac-CCT-250863 HCl induces cell cycle arrest and has good anti-proliferative activity against cancer cells. rac-CCT-250863 HCl can be used in combinati... |